Figure 1From: Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study Change in EQ-5D a) health state index b) overall health rating c) QLQ-C30 global health status . Data are presented as mean (SD) change in score from baseline to safety follow-up.Back to article page